Total Payments
$1,095
2021 Payments
$97.46
Companies
12
Transactions
58
Medicare Patients
293
Medicare Billing
$20,272
Payment Breakdown by Category
Food & Beverage$1,095 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,095 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $394.35 | 25 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $125.00 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $115.75 | 3 | $0 (2019) |
| Amarin Pharma Inc. | $93.30 | 5 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $84.48 | 6 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $75.70 | 4 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $70.81 | 5 | $0 (2018) |
| Novo Nordisk Inc | $47.32 | 3 | $0 (2021) |
| GlaxoSmithKline, LLC. | $29.73 | 2 | $0 (2017) |
| Lilly USA, LLC | $27.34 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $97.46 | 5 | Amarin Pharma Inc. ($41.39) |
| 2020 | $149.86 | 7 | Merck Sharp & Dohme Corporation ($108.00) |
| 2019 | $225.11 | 10 | Janssen Pharmaceuticals, Inc ($104.42) |
| 2018 | $183.25 | 13 | Merck Sharp & Dohme Corporation ($83.90) |
| 2017 | $439.40 | 23 | Merck Sharp & Dohme Corporation ($135.12) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/06/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Cardiovascular | ||||||
| 03/08/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Diabetes | ||||||
| 02/26/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/25/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN, STEGLATRO | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/11/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Cardiovascular | ||||||
| 12/11/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO, STEGLUJAN | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/20/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), VAQTA, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: VACCINE | ||||||
| 11/13/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, BELSOMRA | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/25/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/28/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, BELSOMRA | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/14/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Cardiovascular | ||||||
| 02/07/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: DIABETES | ||||||
| 11/22/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: VACCINE | ||||||
| 10/18/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/07/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/19/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Hypertriglyceridemia | ||||||
| 06/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $91.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 05/31/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY XR | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: DIABETES | ||||||
| 04/05/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Respiratory | ||||||
| 04/01/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 12/07/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET XR, STEGLATRO | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET XR, STEGLATRO | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 30 | 33 | $5,280 | $1,057 |
| 2020 | 8 | 263 | 350 | $52,248 | $19,215 |
Total Patients
293
Total Services
383
Medicare Billing
$20,272
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 21 | $2,940 | $684.17 | 23.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 12 | $2,340 | $372.35 | 15.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 151 | $29,445 | $7,316 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 55 | 55 | $10,780 | $6,918 | 64.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 11 | 11 | $3,575 | $1,986 | 55.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 21 | 22 | $2,390 | $1,323 | 55.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 24 | $3,360 | $930.88 | 27.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 24 | 25 | $700.00 | $448.42 | 64.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 13 | 14 | $1,134 | $149.80 | 13.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 39 | 48 | $864.00 | $143.04 | 16.6% |
About Suzanne Shorten
Suzanne Shorten is a Family Medicine healthcare provider based in Ambler, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215986864.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Suzanne Shorten has received a total of $1,095 in payments from pharmaceutical and medical device companies, with $97.46 received in 2021. These payments were reported across 58 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,095).
As a Medicare-enrolled provider, Shorten has provided services to 293 Medicare beneficiaries, totaling 383 services with total Medicare billing of $20,272. Data is available for 2 years (2020–2021), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Ambler, PA
- Active Since 05/10/2006
- Last Updated 05/29/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1215986864
Products in Payments
- JANUVIA (Drug) $270.58
- PRALUENT (Drug) $125.00
- XARELTO (Drug) $115.75
- Vascepa (Drug) $93.30
- Livalo (Drug) $70.81
- ASMANEX (Drug) $69.10
- FARXIGA (Drug) $60.30
- JARDIANCE (Drug) $53.67
- TRADJENTA (Drug) $49.37
- Ozempic (Drug) $47.32
- PNEUMOVAX 23 (Biological) $32.68
- INCRUSE (Drug) $29.73
- SYMBICORT (Drug) $24.18
- ZOSTAVAX (Biological) $21.99
- MENACTRA (Drug) $18.02
- Uloric (Drug) $13.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.